Logo
Singderm 1 x 2 ml

Singderm 1 x 2 ml

Singderm

Dermal Fillers
  • CE Marked (CE 1023 according to manufacturer) :contentReference[oaicite:23]{index=23}
  • ISO 13485, ISO 9001 certified manufacturer (per manufacturer data) :contentReference[oaicite:24]{index=24}
Hyaluronic Acid Fillers

Description

Singderm® is a monophasic hyaluronic‑acid dermal filler, with 24 mg/ml HA and 0.3% lidocaine in physiologic buffer, provided in a 2 ml pre‑filled disposable syringe. It is designed for injection into mid to deep dermis or subcutaneous tissue to correct wrinkles, restore lost facial volume, and improve facial contours. :contentReference[oaicite:0]{index=0}

Bnefits

  • High HA concentration (24 mg/ml) for effective volume restoration and lift. :contentReference[oaicite:1]{index=1}
  • Contains 0.3% lidocaine for more comfortable, less painful injections. :contentReference[oaicite:2]{index=2}
  • Mono‑phasic, smooth gel ensures natural-looking results and good tissue integration. :contentReference[oaicite:3]{index=3}
  • CE‑marked and produced via microbial fermentation (non‑animal origin HA), reducing risk of immunogenic reactions. :contentReference[oaicite:4]{index=4}
  • Results can last 6–12 months depending on treatment area, HA amount, and patient metabolism. :contentReference[oaicite:5]{index=5}

Indications

  • Correction of mid to deep skin depressions, wrinkles and folds (e.g., nasolabial folds, marionette lines). :contentReference[oaicite:6]{index=6}
  • Restoring age‑related facial volume loss (cheeks, temples, chin). :contentReference[oaicite:7]{index=7}
  • Lip contouring and volume enhancement. :contentReference[oaicite:8]{index=8}
  • Facial contouring and reshaping (jawline, cheeks). :contentReference[oaicite:9]{index=9}

Composition

  • Sodium hyaluronate (cross‑linked HA) 24 mg/ml, non‑animal origin, microbial‑fermentation sourced. :contentReference[oaicite:10]{index=10}
  • Lidocaine hydrochloride 0.3% for anaesthesia during injection. :contentReference[oaicite:11]{index=11}
  • Physiologic phosphate buffer, sterile, pyrogen‑free. :contentReference[oaicite:12]{index=12}

Formulation

  • Monophasic, homogeneous viscous gel suspension with cross‑linked HA and lidocaine. :contentReference[oaicite:13]{index=13}

Packaging

  • Pre‑filled disposable syringe (2 ml). :contentReference[oaicite:14]{index=14}
  • Comes with instruction leaflet and traceability labels. :contentReference[oaicite:15]{index=15}

Usage

  • Intended for use by trained medical professionals only. :contentReference[oaicite:16]{index=16}
  • Inject into mid to deep dermis or subcutaneous tissue, depending on indication. :contentReference[oaicite:17]{index=17}
  • Use a separate sterile needle — needles are not included. :contentReference[oaicite:18]{index=18}
  • Observe standard aseptic and patient‑safety protocols.

Contraindications

  • Known hypersensitivity to HA or lidocaine
  • Active skin infection or inflammation at injection site
  • Pregnancy or breastfeeding (depending on local regulations)

Adverse Effects

  • Temporary redness, swelling, bruising or mild discomfort at injection site — common with dermal fillers. :contentReference[oaicite:19]{index=19}
  • Risk of rare complications such as infection, granuloma formation or vascular occlusion (general filler risk). :contentReference[oaicite:20]{index=20}

Storage Conditions

  • Store at 2–30 °C per manufacturer instructions. :contentReference[oaicite:21]{index=21}
  • Keep unopened until use; do not reuse or resterilize. :contentReference[oaicite:22]{index=22}

Duration

Onset

Immediate volumizing / lifting effect (typical for HA fillers)

Browse more Dermal Fillers

Top Treatments

Top Cities in the UK